The Coordinated Actions of TIM-3 on Cancer and Myeloid Cells in the Regulation of Tumorigenicity and Clinical Prognosis in Clear Cell Renal Cell Carcinomas

Cancer Immunology Research
Yoshihiro KomoharaMasahisa Jinushi

Abstract

Clear cell renal cell carcinoma (ccRCC) is one of most common cancers in urogenital organs. Although recent experimental and clinical studies have shown the immunogenic properties of ccRCC as illustrated by the clinical sensitivities to various immunotherapies, the detailed immunoregulatory machineries governing the tumorigenicity of human ccRCC remain largely obscure. In this study, we demonstrated the clinical significance and functional relevance of T-cell immunoglobulin and mucin domain-containing molecule-3 (TIM-3) expressed on tumor cells and myeloid cells in patients with ccRCC. TIM-3 expression was detected on cancer cells and CD204(+) tumor-associated macrophages (TAM), and higher expression level of TIM-3 was positively correlated with shorter progression-free survival (PFS) in patients with ccRCC. We found that TIM-3 expression was detected on a large number of tumors, and there was significant correlation between an increased number of TAMs and high expression level of TIM-3 in patients with ccRCC. Furthermore, TIM-3 rendered RCC cells with the ability to induce resistance to sunitinib and mTOR inhibitors, the standard regimen for patients with ccRCC, as well as stem cell activities. TIM-3 expression was induced on ...Continue Reading

References

Aug 7, 2002·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Takuma SakuraiKazuo Motoyoshi
Nov 16, 2005·Nature Immunology·Chen ZhuVijay K Kuchroo
Nov 11, 2006·The Journal of Investigative Dermatology·Zoltan WienerAndras Falus
Jan 12, 2007·The New England Journal of Medicine·Robert J MotzerRobert A Figlin
Jun 1, 2007·The New England Journal of Medicine·Gary HudesUNKNOWN Global ARCC Trial
Jun 3, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert J MotzerRobert A Figlin
Jun 12, 2010·Immunological Reviews·Gordon J FreemanRosemarie H DeKruyff
Nov 30, 2010·Cell Stem Cell·Yoshikane KikushigeKoichi Akashi
Jan 12, 2011·Proceedings of the National Academy of Sciences of the United States of America·Dimitrios IliopoulosKevin Struhl
Mar 9, 2011·Proceedings of the National Academy of Sciences of the United States of America·Max JanRavindra Majeti
Apr 2, 2011·Cancer Science·Yoshihiro KomoharaMotohiro Takeya
Jun 24, 2011·Trends in Immunology·Kaori SakuishiVijay K Kuchroo
Jul 13, 2011·Proceedings of the National Academy of Sciences of the United States of America·Masahisa JinushiHideaki Tahara
Jul 21, 2011·Nature Immunology·Yinon Ben-Neriah, Michael Karin
Apr 14, 2012·The Journal of Urology·Amit R PatelScott E Eggener
Apr 17, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hang LiWeiping Zou
May 4, 2012·Cancer Research·Satoshi NishizawaNoriyuki Sato
May 16, 2012·American Journal of Clinical Pathology·Xuewei ZhuangChunhong Ma
Aug 23, 2012·Nature Immunology·Daolin Tang, Michael T Lotze

❮ Previous
Next ❯

Citations

Dec 2, 2015·Advanced Drug Delivery Reviews·Yoshihiro KomoharaMotohiro Takeya
Aug 15, 2015·Cancer Letters·Yu Sun
Jul 23, 2016·Pathology International·Motohiro Takeya, Yoshihiro Komohara
Nov 4, 2016·Analytical Cellular Pathology (Amsterdam)·Olga V KovalevaAlexei Gratchev
Mar 5, 2017·Immunological Reviews·Madhumita DasVijay K Kuchroo
Jun 21, 2017·Medical Molecular Morphology·Hiromu YanoYoshihiro Komohara
Sep 22, 2017·International Reviews of Immunology·Carolina SchäferLeandro J Carreño
Jun 1, 2018·Journal of Immunology Research·Magdalena Witkowska, Piotr Smolewski
Dec 22, 2019·Cells·Tsung-Cheng LinHung-Chi Cheng
Feb 23, 2020·Journal of Clinical Laboratory Analysis·Ming ChenZhigang Hu
Jul 1, 2020·Journal for Immunotherapy of Cancer·Nandini AcharyaAna Carrizosa Anderson
Oct 13, 2018·Journal of Hematology & Oncology·Feifei LiuZhi Chen
Dec 9, 2017·Medical Molecular Morphology·Takanobu MotoshimaYoshihiro Komohara
Feb 11, 2020·Frontiers in Oncology·Bella S GuerrouahenEmmanuel T Akporiaye
Sep 4, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jamie LimTorsten O Nielsen
Oct 23, 2020·Journal of Research in Medical Sciences : the Official Journal of Isfahan University of Medical Sciences·Narges Zargar BalajamFarzad Kompani
Jan 12, 2021·Frontiers in Oncology·Mazdak Ganjalikhani HakemiAlexandr V Bazhin
Oct 31, 2020·Signal Transduction and Targeted Therapy·Yuqing CaoFeng Xu
Nov 1, 2020·Translational Oncology·Renpei KatoWataru Obara
Feb 26, 2020·Current Stem Cell Research & Therapy·Haibao Zhang, Guodong Zhu
Mar 27, 2021·Signal Transduction and Targeted Therapy·Zhaojun Duan, Yunping Luo
Aug 14, 2021·Acta Pharmaceutica Sinica. B·Javad MasoumiHamid Reza Mirzaei
Aug 7, 2019·Chemotherapy·Grazia R TundoStefano Marini

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adenocarcinoma, Clear Cell

Clear Cell Adenocarcinoma is a tumor that arises in the female genital tract and is characterized by cells that appear clear under the microscope. Discover the latest research here.